Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Gainers

• Reata Pharmaceuticals Inc (NASDAQ:RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
• OncoSec Medical Incorporated (NASDAQ:ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
• Lionheart III Corp (NASDAQ:LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
• China Pharma Holdings Inc (NASDAQ:CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
• Helbiz Inc (NASDAQ:HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
• Sarepta Therapeutics Inc (NASDAQ:SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
• Landos Biopharma Inc (NASDAQ:LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
• China SXT Pharmaceuticals Inc (NASDAQ:SXTC) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
• Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
• Bilibili Inc - ADR (NASDAQ:BILI) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.

Losers

• OKYO Pharma (NASDAQ:OKYO) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
• Novavax Inc (NASDAQ:NVAX) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
• Marqeta Inc (NASDAQ:MQ) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
• Beamr Imaging Ltd. (NASDAQ:BMR) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
• Obseva SA (NASDAQ:OBSV) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
• Brightspire Capital Inc (NYSE:BRSP) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
• Performance Shipping Inc (NASDAQ:PSHG) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
• Grove Collaborative Holdings Inc (NYSE:GROV) fell 12.7% to $0.38 in pre-market trading.
• Catalyst Biosciences Inc (NASDAQ:CBIO) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
• AMC Entertainment Holdings Inc (NYSE:AMC) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.

Now Read This: Top 5 Health Care Stocks That You May Want To Dump In Q1 2023